SHOCKING: Evgn - You Need To See This

Don't Sow Your Oats With These Failing Stocks

High inflation, labor shortage, and extreme weather conditions are expected to keep the agriculture industry under pressure this year. Therefore, fundamentally weak agriculture stocks Local Bounti (LOCL), Evogene (EVGN), and Edible Garden (EDBL) might be best avoided now. Read on.

StockNews.com · Mar 30, 2023

1 ETF and 3 Stocks With Dividend Yields Over 6% Right Now

The Fed’s aggressive treatment of the inflationary situation is expected to create more volatility in the market. Given the uncertain macro backdrop, we believe high-yielding ETF iShares MSCI Brazil (EWZ) and stocks ICL Group (ICL), Alliance Resource Partners (ARLP), and Global Partners (GLP) might be solid buys. Read on….

StockNews.com · Aug 30, 2022

RBC Capital Cuts EverGen Infrastructure Price Target By 16%

EverGen Infrastructure Corp (TSXV: EVGN) price target has been lowered to C$5 from C$6 by RBC Capital analyst Nelson Ng. The analyst maintained the Outperform rating on the shares. The analyst states that EverGen has a number of near-term opportunities across Canada to grow its RNG production capacity significantly.

Benzinga · May 26, 2022

Recap: Evogene Q4 Earnings

  Evogene (NASDAQ:EVGN) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga · Mar 10, 2022

A Preview Of Evogene's Earnings

Evogene (NASDAQ:EVGN) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement. Analysts estimate that Evogene will report an earnings per share (EPS) of $-0.17.

Benzinga · Mar 9, 2022

Medical-Grade Cannabis Developer Canonic Appoints Ex-SEO At Israeli Ministry Of Health To Its Board

Medical-grade cannabis developer Canonic Ltd., and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN), announced that professor Itamar Grotto will be joining its board of directors.

Benzinga · Feb 16, 2022

Evogene Co, 'When Biology Meets Disruptive Technologies,' Confirms Earnings Results Release Date

Computational biology company Evogene Ltd. (NASDAQ: EVGN)  will release its financial results for the full year and fourth quarter of 2021 on March 10, 2022.

Benzinga · Feb 15, 2022

Certain Marijuana Varieties Have 'Impressive' Pain Relief Properties, Evogene's Cannonic's Pre-Clinical Study Confirms

Medical grade cannabis products developer Canonic Ltd., a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), revealed Tuesday that it had seen positive results in pre-clinical studies in inflammatory and pain model systems.

Benzinga · Jan 18, 2022